{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T16:35:08Z","timestamp":1694018108318},"reference-count":28,"publisher":"Korean Association of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Korean J Intern Med"],"DOI":"10.3904\/kjim.2003.18.1.21","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T06:18:39Z","timestamp":1438237119000},"page":"21-28","source":"Crossref","is-referenced-by-count":4,"title":["Treatment Outcome of Adult Acute Lymphocytic Leukemia with VPDL Regimen: analysis of Prognostic Factors"],"prefix":"10.3904","volume":"18","author":[{"given":"Sook Ryun","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Do Yeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Yoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In Sil","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Soo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seon Yang","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byuoung Gook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noe Kyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2270","published-online":{"date-parts":[[2003,3,31]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200001000-00002"},{"key":"ref2","first-page":"139","volume-title":"Therapy of the newly-diagnosed adults with acute lymphoblastic leukemia","author":"Hoelzer","year":"1993"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-82249-0_7"},{"key":"ref4","first-page":"199","volume-title":"Therapy of adult ALL: overview of 2 successive EORTC studies (ALL-2 & ALL-3)","author":"Stryckmans","year":"1992"},{"key":"ref5","first-page":"267","volume-title":"Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: A prospective randomized trial by Cancer and Leukemia Group B","author":"Gottlieb","year":"1984"},{"key":"ref6","first-page":"182","volume-title":"GIMEMA ALL 0288: A multicentric study on adult acute lymphoblastic leukemia. Preliminary results","author":"Mandelli","year":"1992"},{"key":"ref7","first-page":"832","volume-title":"Severe toxicity limits intensification of induction therapy for acute lymphoblastic leukemia","author":"Weiss","year":"1993"},{"key":"ref8","first-page":"1242","volume-title":"Improved results of treatment of adult acute lymphoblastic leukemia","author":"Linker","year":"1987"},{"key":"ref9","first-page":"1346","volume-title":"Treatment of adult acute lymphoblastic leukemia","author":"Kim","year":"1986"},{"key":"ref10","first-page":"504","volume-title":"Remission Induction with Vincristine, Prednisolone, Daunorubicin, L-asparaginase in Adult Acute Lymphocytic Leukemia","author":"Im","year":"1990"},{"key":"ref11","first-page":"287","volume-title":"Effect of Treatment with Vincristine, Prednisolone, Daunorubicin, and L-asparaginase in Adult Acute Lymphocytic Leukemia","author":"You","year":"1994"},{"key":"ref12","first-page":"315","volume-title":"Results of treatment and Prognostic Factors of Lymphoblastic Leukemia; An analysis in 33 Patients","author":"Cho","year":"1997"},{"key":"ref13","first-page":"376","volume-title":"Effect of Treatment with Intensified Induction Regimen in Adult Acute Lymphocytic Leukemia","author":"Seok","year":"1997"},{"key":"ref14","first-page":"233","volume-title":"L-17M Chemotherapy of Acute Lymphocytic Leukemia in Adults: Final Report","author":"Woo","year":"1995"},{"key":"ref15","first-page":"67","volume-title":"L-17M Chemotherapy of Acute Lymphocytic Leukemia in Adults","author":"Kim","year":"1992"},{"key":"ref16","first-page":"31","volume-title":"Efficacy of Therapy in the Adult Acute Lymphocytic Leukemia","author":"Sohn","year":"1993"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1981.tb02684.x"},{"key":"ref18","first-page":"2814","volume-title":"Treatment of adult lymphoblastic leukemia with intensive cyclical chemotherapy: A follow-up report","author":"Linker","year":"1991"},{"key":"ref19","first-page":"123","volume-title":"Prognostic Factors in a Multicenter Study for Treatment of Acute Lymphoblastic Leukemia in Adults","author":"Hoelzer","year":"1988"},{"key":"ref20","first-page":"57","volume-title":"Treatment of Acute Lymphoblastic Leukemia in Adults With Intensive induction, Consolidation, and Maintenance Chemotherapy","author":"Hussein","year":"1989"},{"key":"ref21","first-page":"994","volume-title":"Results of the Vincristine, Doxorubicin, and Dexa-methasone Regimen in Adults With Standard-and High-Risk Acute Lymphocytic Leukemia","author":"Kantarjian","year":"1990"},{"key":"ref22","first-page":"2025","volume-title":"A Five-Drug Remission Induction Regimen With Intensive Consolidation for Adults With Acute Lymphoblastic Leukemia: Cancer and Leukemia Group B Study 8811","author":"Larson","year":"1995"},{"key":"ref23","first-page":"160","volume-title":"Acute lymphoblastic leukemia in adults","author":"Clarkson","year":"1985"},{"key":"ref24","first-page":"1014","volume-title":"A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: The Memorial Hospital experience since 1969","author":"Gaynor","year":"1988"},{"key":"ref25","first-page":"175","volume-title":"The German Multicentre Trials for treatment of acute lymphoblastic leukemia in adults","author":"Hoelzer","year":"1992"},{"key":"ref26","first-page":"2002","volume-title":"The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by cancer and leukemia group B","author":"Ellison","year":"1991"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1385\/1-59259-307-0:143"},{"key":"ref28","first-page":"58","volume-title":"Adult acute lymphoblastic leukemia: Results of the Iowa HOP-L protocol","author":"Radford","year":"1989"}],"container-title":["The Korean Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.kjim.org\/upload\/kjim-18-1-21-4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T09:50:22Z","timestamp":1566294622000},"score":1,"resource":{"primary":{"URL":"http:\/\/kjim.org\/journal\/view.php?doi=10.3904\/kjim.2003.18.1.21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3,31]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,3,30]]}},"URL":"https:\/\/doi.org\/10.3904\/kjim.2003.18.1.21","relation":{},"ISSN":["1226-3303","2005-6648"],"issn-type":[{"value":"1226-3303","type":"print"},{"value":"2005-6648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,31]]}}}